ITMI921720A0 - Fosforotidati di oligonucleotidi ciclici - Google Patents

Fosforotidati di oligonucleotidi ciclici

Info

Publication number
ITMI921720A0
ITMI921720A0 IT92MI1720A ITMI921720A ITMI921720A0 IT MI921720 A0 ITMI921720 A0 IT MI921720A0 IT 92MI1720 A IT92MI1720 A IT 92MI1720A IT MI921720 A ITMI921720 A IT MI921720A IT MI921720 A0 ITMI921720 A0 IT MI921720A0
Authority
IT
Italy
Prior art keywords
phosphorotidates
cyclic oligonucleotides
oligonucleotides
cyclic
Prior art date
Application number
IT92MI1720A
Other languages
English (en)
Inventor
Carlo Battistini
Maria Gabriella Brasca
Silvia Fustinoni
Domenico Ungheri
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI921720A0 publication Critical patent/ITMI921720A0/it
Publication of ITMI921720A1 publication Critical patent/ITMI921720A1/it
Application granted granted Critical
Publication of IT1255222B publication Critical patent/IT1255222B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ITMI921720A 1991-07-18 1992-07-15 Fosforotidati di oligonucleotidi ciclici IT1255222B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9115586A GB2257704B (en) 1991-07-18 1991-07-18 Cyclic oligonucleotides phosphorothioates

Publications (3)

Publication Number Publication Date
ITMI921720A0 true ITMI921720A0 (it) 1992-07-15
ITMI921720A1 ITMI921720A1 (it) 1994-01-15
IT1255222B IT1255222B (it) 1995-10-20

Family

ID=10698606

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921720A IT1255222B (it) 1991-07-18 1992-07-15 Fosforotidati di oligonucleotidi ciclici

Country Status (5)

Country Link
US (1) US5547941A (it)
JP (1) JPH05186495A (it)
DE (1) DE4223438A1 (it)
GB (1) GB2257704B (it)
IT (1) IT1255222B (it)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390441A1 (en) * 1999-11-08 2001-05-17 Origenix Technologies, Inc. Combinatorial library synthesis and pharmaceutically active compounds produced thereby
KR20020069627A (ko) * 2001-02-27 2002-09-05 동부한농화학 주식회사 육환의 아자슈거를 가진 뉴클레오타이드 유도체를 포함한포스포로티오에이트 올리고뉴클레오타이드 및 이들의에이즈 치료제로서의 새로운 용도
US6881831B2 (en) * 2001-05-16 2005-04-19 Migenix Inc. Nucleic acid-based compounds and methods of use thereof
US7345163B2 (en) * 2002-08-28 2008-03-18 Quiatech Ab Process for separating and deprotecting oligonucleotides
US8367716B2 (en) 2003-07-28 2013-02-05 Karaolis David K R Method for attentuating virulence of microbial pathogens and for inhibiting microbial biofilm formation
US20070149451A1 (en) * 2003-11-17 2007-06-28 Holmes David G Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
JP4931798B2 (ja) * 2004-03-15 2012-05-16 ケイ．アール． カラオリス，デイヴィッド 免疫、炎症または神経保護応答のための方法
EP1782826A1 (en) * 2005-11-08 2007-05-09 GBF Gesellschaft für Biotechnologische Forschung mbH PQS and c-diGMP and its conjugates as adjuvants and their uses in pharmaceutical compositions
WO2009133560A1 (en) * 2008-04-29 2009-11-05 Smart Assays Non-hydrolyzable and permeable cyclic bis-[nucleotide monophosphate] derivatives and uses thereof
CN102199183B (zh) * 2010-03-26 2013-12-18 北京大学 环二鸟苷酸及其类似物和制备方法
NZ702392A (en) 2012-06-08 2017-03-31 Aduro Biotech Compositions and methods for cancer immunotherapy
EA201590396A1 (ru) * 2012-12-13 2015-12-30 Адуро Биотек, Инк. Композиция, содержащая циклические пуриновые динуклеотиды с определенной стереохимией, и способ ее получения и применения
WO2014109256A1 (ja) * 2013-01-09 2014-07-17 国立大学法人東北大学 トリアゾール連結型環状ジヌクレオチド類縁体
ES2982836T3 (es) 2013-04-29 2024-10-17 Memorial Sloan Kettering Cancer Center Composiciones y métodos para alterar la señalización de segundos mensajeros
EP2992000B1 (en) 2013-05-03 2020-07-08 The Regents of The University of California Cyclic di-nucleotide induction of type i interferon
US9549944B2 (en) 2013-05-18 2017-01-24 Aduro Biotech, Inc. Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
ME03586B (me) 2013-05-18 2020-07-20 Univ California Sastavi i metode za aktiviranje signaliziranja koje je zavisno od .,stimulatora gena za interferon"
US10176292B2 (en) 2013-07-31 2019-01-08 Memorial Sloan-Kettering Cancer Center STING crystals and modulators
WO2015185565A1 (en) 2014-06-04 2015-12-10 Glaxosmithkline Intellectual Property Development Limited Cyclic di-nucleotides as modulators of sting
GB201501462D0 (en) 2015-01-29 2015-03-18 Glaxosmithkline Ip Dev Ltd Novel compounds
JO3746B1 (ar) 2015-03-10 2021-01-31 Aduro Biotech Inc تركيبات وطرق لتنشيط الإشارات المعتمدة على "منبه أو تحفيز جين انترفيرون"
JP6411676B2 (ja) 2015-12-03 2018-10-24 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｓｔｉｎｇの調節因子としての環状プリンジヌクレオチド
EP3507367A4 (en) 2016-07-05 2020-03-25 Aduro BioTech, Inc. CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF
KR102569881B1 (ko) 2016-07-06 2023-08-22 에프-스타 테라퓨틱스 인코포레이티드 질병 치료용 화합물, 조성물 및 방법
US10266558B2 (en) * 2016-10-07 2019-04-23 Alexandre Vasilievich Ivachtchenko Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof
PT3512861T (pt) 2016-12-01 2021-04-29 Takeda Pharmaceuticals Co Dinucleotídeos cíclicos
US20200055883A1 (en) 2017-02-17 2020-02-20 Eisai R&D Management Co., Ltd. Cyclic di-nucleotides derivative for the treatment of cancer
WO2019051488A1 (en) 2017-09-11 2019-03-14 Sperovie Biosciences, Inc. COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
WO2019051489A1 (en) 2017-09-11 2019-03-14 Sperovie Biosciences, Inc. COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
MX2020004858A (es) 2017-11-10 2020-10-01 Takeda Pharmaceuticals Co Compuestos moduladores de sting y metodos de elaboracion y uso.
MX2020012964A (es) 2018-06-01 2021-02-16 Eisai R&D Man Co Ltd Metodos para el tratamiento de cancer de vejiga.
US12291548B2 (en) 2018-07-10 2025-05-06 Sperovie Biosciences, Inc. Compounds, compositions, and methods for the treatment of disease
MX2020013322A (es) 2018-08-16 2021-02-22 Eisai R&D Man Co Ltd Sales de compuestos y cristales de los mismos.
AU2020267486B2 (en) 2019-05-09 2025-12-18 Aligos Therapeutics, Inc. Modified cyclic dinucleoside compounds as STING modulators
CN115160392B (zh) * 2020-10-20 2026-01-30 泰励生物科技（上海）有限公司 多功能环二核苷酸及其用途
WO2022083584A1 (zh) * 2020-10-20 2022-04-28 泰励生物科技（上海）有限公司 多功能环二核苷酸及其用途
MX2023005381A (es) 2020-11-09 2023-05-23 Takeda Pharmaceuticals Co Conjugados de anticuerpo y farmaco.

Also Published As

Publication number Publication date
GB2257704B (en) 1995-03-01
GB2257704A (en) 1993-01-20
ITMI921720A1 (it) 1994-01-15
DE4223438A1 (de) 1993-01-21
IT1255222B (it) 1995-10-20
US5547941A (en) 1996-08-20
GB9115586D0 (en) 1991-09-04
JPH05186495A (ja) 1993-07-27

Similar Documents

Publication Publication Date Title
ITMI921720A1 (it) Fosforotidati di oligonucleotidi ciclici
FI931888L (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
FI931202L (fi) Antifungala cykliska peptider och foerfarande foer framstaellning av dessa
FI935113L (fi) Oligonukleotidanaloger med modifierad stomme
FI934223L (fi) Heterocykliscykliska aminderivat
FI932230A7 (fi) Parannettuja epoksisilikonisynteesejä
DE69217696D1 (de) Zahnbürste
BR9005768A (pt) Estrutura turbilionar de varios estagios
FI923119A7 (fi) Krutdriven montageanordning med magasin foer faestelement
NO921810D0 (no) Anvendelse av acetaler
FI925609L (fi) Foerfarande foer framstaellning av sykliska sulfater
DE69218229D1 (de) Entschwefelungsbehandlung
FI923585L (fi) Anvaendning av en tvaettpress i en alkalitillsatsprocess foer massa
FI935205A0 (fi) Foerfarande foer framstaellning av kemitermomekanisk massa
FI925259A0 (fi) Kemiskt foerfarande
IT228644Y1 (it) Struttura di pennello
ITMI912654A1 (it) Combinazione di estrusore-calandra
ITMI913464A1 (it) Procedimento per la neutralizzazione di perfluoropoliossialchileni
FI924076L (fi) Cykliska nitroner
ITMI912117A1 (it) Oligonucleotidi antisenso
ITMI910243V0 (it) Struttura di dispositivo fermacorda
ITMI921096A1 (it) Dosatore-applicatore di piombi da pesca
IT225839Y1 (it) Struttura di pattino
SE9102613D0 (sv) Doftgivare
ITTV910080A1 (it) Struttura di occhiale aerato

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950628